Willow Bracket (Phellinus igniarius): A Comprehensive Reference
1. Identity, Taxonomy, and Morphology
Scientific name: Phellinus igniarius (syn. Phellinus trivialis), commonly known as the willow bracket, fire sponge, false tinder polypore, punk ash polypore, or false tinder conk, is a fungus of the family Hymenochaetaceae. Additional synonyms include Boletus igniarius L., Polyporus igniarius (L.) Fr., Fomes igniarius (L.) Cooke, Fomes trivialis Bres., and Phellinus trivialis (Bres.) Kreisel.
In 1776 Carl Linnaeus described this species, giving it the name Boletus igniarius. It was the French mycologist Lucien Quélet who, in 1886, transferred the Willow Bracket fungus to the genus Phellinus, renaming it as Phellinus igniarius, the scientific name by which it is generally recognised nowadays. In 1886 the genus Phellinus was circumscribed by French mycologist Lucien Quélet; the generic name comes from phell- meaning cork, while the suffix -inus denotes a superlative.
Phellinus igniarius is a general term for a class of fungi that belongs to Basidiomycota, Agaricomycetes, Hymenochaetales and Hymenochaetaceae. Like other members of the genus Phellinus, it lives by saprotrophic nutrition, in which the lignin and cellulose of a host tree is degraded and is a cause of white rot. The fungus forms perennial fruiting bodies that rise as woody-hard, hoof or disc-shaped brackets from the bark of the infested living tree or dead log. The tree species is often willow but it may be commonly found on birch and alder and other broad-leafed trees.
The top surface is grey to blackish, often becoming deeply cracked and "checked" as it ages, resembling charred wood. The width is 15–25 cm and 8–15 cm thick, bulbous shape initially, later flat. The area is grey, darkening with time, sometimes cracked. Flesh thickness is 2 cm. It is woody, zoned, and has the color of dark-reddish-brown to chestnut-brown. Experts believe this fungus is probably a "complex" of several species rather than a single species. Fruitbodies can continue growing for many years, feeding on the remains of the host tree long after it has died.
A characteristic feature of the genus Phellinus is the presence of setae, sterile, lance-shaped elements with thick, brown walls, measuring 15–25 × 5–8 μm. The basidiospores are spherical or subspherical in shape, hyaline (transparent) and with a smooth wall, measuring 5–7 × 4–6 μm.
Its Latin name, igniarius, literally means "fire-maker," a nod to its ancient history as a slow-burning tinder used to transport embers from one campsite to the next.
2. Taxonomy Notes and Species Complexity
There are several other Phellinus species, and P. igniarius may be a species complex requiring DNA analysis to separate. In the scientific literature, the closely related species Phellinus linteus (also called "Sanghuang" in Chinese) is sometimes conflated with P. igniarius, and the two share many pharmacological properties. Polysaccharides from their fruiting bodies show strong immunomodulatory activity. Readers should be aware that older studies using the "Sanghuang" name may refer to either or both species, as taxonomic distinctions were not always rigorously applied in earlier Chinese medical literature.
3. Traditional and Historical Uses
3.1 Prehistoric and Archaeological Record
Archaeological finds have revealed that humans knew and used the Willow Bracket since prehistory. The famous Ötzi, the Iceman who lived about 5,300 years ago and was discovered in 1991 in the Ötztal Alps, carried with him various fungi, including probably specimens of Phellinus igniarius. Although certain identification is complicated by the state of preservation of the finds, this discovery suggests that knowledge of the medicinal properties of this fungus dates back at least to the Copper Age.
3.2 Traditional Chinese Medicine (TCM)
Phellinus igniarius (Sanghuang) is a traditional Chinese medicinal fungus which has been widely used in traditional Chinese medicine for more than 2,000 years. The first use of Phellinus igniarius was reported in the oldest Chinese medicinal book, Shennong's Compendium of Materia Medica, which reported the use of Phellinus igniarius for the treatment of various disease conditions, such as stomach pain and amenorrhea; the use of this fungus is also correlated with prolonged life, detoxication, and improved digestion after long-term use.
P. igniarius has been used for the treatment of bellyache, fester, and bloody gonorrhea in traditional Chinese medicine for thousands of years. In several folk herbal medicine formulas or recipes, P. igniarius is used to treat stomach aches and arthritis. Traditional applications in Chinese clinical empirical practice mainly include treating hemorrhage, hemostasis, and diseases related to female menstruation.
3.3 Alaska Native Peoples (Iqmik)
The Inupiaq and Yup'ik Eskimos of western Alaska have used Phellinus igniarius for hundreds of years by burning the basidiocarps and mixing the ashes with tobacco. A previous publication documented the historic use of this fungus and documented natural history museum collections of sporophores and special ornate boxes for holding the fungus ashes. Iqmik, also called blackbull, is a smokeless tobacco product. It is used mainly by Native Americans in parts of Alaska and is made from a mixture of tobacco and the ash of Phellinus igniarius, informally called punk ash. In 2005, over 50% of Yupik-Eskimos were reported to consume iqmik.
Iq'mik is prepared by burning a woody fungus (Phellinus igniarius) from birch trees and mixing the ash with leaf tobacco. The ash is mixed with tobacco leaves, pre-chewed in the mouth or mixed with water, and stored in containers to use later. The Smithsonian Institution National Museum of Natural History has unusual boxes made by the Inuit of Alaska in the late 1800s to hold the ashes of Phellinus igniarius basidiocarps. The fungus was burned and the ashes mixed with tobacco to give it "a powerful kick." Museum collections of P. igniarius indicate that its use by Native Americans as a masticatory or for smoking purposes was widespread across North America.
Museum collections show that Phellinus igniarius was also used by the Micmac of Nova Scotia, Inuit of Labrador, Blackfoot of the North American Plains, and the Kwakiutl of the Pacific Northwest.
3.4 European and Siberian Traditional Uses
In Europe, the fungus was processed into a soft, velvety substance known as esca or amadou, which caught sparks effectively from flint and steel kits and maintained a smolder without open flame, facilitating fire transport and starting since prehistoric times. This woody, corky texture allowed it to serve as reliable kindling in survival contexts across temperate regions.
Recent ethnomycological studies have documented the use of the bracket in the traditional medicine of the Sami, the indigenous population of Lapland, who used it to treat respiratory disorders and as a hemostatic agent. In Siberia, the fungus was traditionally chewed as a tobacco substitute, a practice that might have pharmacological implications given the psychoactive properties of some compounds present in the fungus.
4. Key Constituents and Active Compounds
P. igniarius is rich in secondary metabolites with biological activities, such as polysaccharides, polyphenols, flavonoids, and other chemical species. Phelligridins are a class of chemical compounds from P. igniarius that possess complex chemical structures with extensive pharmacological activities. Polysaccharides (especially β-glucan), steroids (21-homopregnene derivatives), flavonoids, coumarins, styrylpyrones (phelligridines A–J), macrolides (phelligridimer A), and sesquiterpenes are believed to be responsible for the biological activity observed in extracts of this fungus.
4.1 Polysaccharides and β-Glucans
The polysaccharides from P. igniarius were characterized by HPLC, GC-MS, and NMR. The polysaccharides from P. igniarius mainly contained glucose with minor proportions of mannose, galactose, xylose, arabinose, and rhamnose. Methylation analyses showed that the glycosidic linkages were mostly 1→3, 1→6 or 1→3,6.
Phellinus polysaccharides activate humoral immune regulation and cellular immune regulation, and promote the body to release a large amount of immune-stimulating products.
4.2 Flavonoids
Five flavonoids and two coumarins were isolated from Phellinus igniarius and their structures were identified as naringenin, sakuranetin, aromadendrin, folerogenin, eriodictyol, coumarin, and scopoletin. All these compounds were obtained from this genus for the first time. Seven flavonoids (phelligrin A, phelligrin B, naringenin, sakuranetin, aromadendrin, folerogenin, eriodictyol, 7,3′-dihydroxy-5′-methoxyisoflavone, and taxifolin) were isolated and purified from the ethanol extraction of fruiting bodies of P. igniarius.
Currently, flavonoid compounds (e.g., flavones and dihydroflavones) are a class of secondary metabolites with high content in both fruiting bodies and mycelia of Phellinus spp., and at least 22 flavonoid compounds have been isolated from various Phellinus spp.
4.3 Hispidin and Styrylpyrone Derivatives
Hispidin (HIP) and its derivatives are a class of natural fungal metabolites that possess complex chemical structures with extensive pharmacological activities. Phellinus igniarius is the most common source of HIP. A representative group of medicinal fungi, including P. linteus, P. igniarius, P. ribis, I. obliquus, and I. xeranticus, were shown to produce a large and diverse range of styrylpyrone-type polyphenol pigments that exhibited various biological activities, including anti-oxidative, anti-inflammatory, cytotoxic, anti-platelet aggregation, anti-diabetic, anti-dementia, and anti-viral effects.
The main active components of wild and cultivated P. igniarius polyphenols included protocatechuic aldehyde, hispidin, davallialactone, phelligridimer A, hypholomine B, and inoscavin A as identified by UPLC-ESI-qTOF-MS.
4.4 Sesquiterpenes
Phellinus igniarius is a saprophytic fungus that is a good source of tremulane sesquiterpenes. These compounds showed significant vasorelaxant activity of vasoconstriction in Sprague-Dawley mice induced by phenylephrine, and the relaxation rate was approximately 46.6%.
4.5 Additional Polyphenols Identified by Chromatography
Seven polyphenol compounds named 3,4-dihydroxybenzaldehyde, 4-(3,4-dihydroxyphenyl)-3-buten-2-one, inonoblin C, phelligridin D, inoscavin C, phelligridin C, and interfungin B were identified from the ethanolic extract of P. igniarius fruiting bodies by chromatographic methods.
5. Mechanisms of Action
5.1 Immunomodulation
P. igniarius has long been used for clinical application and basic research to improve the immunity of the body. Phellinus polysaccharides activate humoral immune regulation and cellular immune regulation, and promote the body to release a large amount of immune-stimulating products. A large number of studies on polysaccharides or flavonoids from P. igniarius suggest that these natural products play an important role in regulating the composition and abundance of intestinal flora and improving the body's immunity.
5.2 Anti-inflammatory Pathways
Phellinus igniarius (PI) exerts antioxidative and anti-inflammatory effects on RAW264.7 mouse macrophages. The MTT assay revealed that PI exerted no significant cytotoxicity in the RAW 264.7 macrophage cells. PGE2 and NO synthesis were significantly suppressed in the PI-treated groups compared to the lipopolysaccharide-treated group. Real-time PCR analysis revealed modulation of the mRNA levels of COX-2, iNOS, IL-1α, IL-1β, IL-6, and tumor necrosis factor (TNF)-α.
5.3 Anti-gout Mechanism (Xanthine Oxidase Inhibition)
Wild and cultivated P. igniarius showed similar activities in reducing uric acid levels through inhibiting xanthine oxidase (XO) activity and down-regulating the levels of uric acid, creatinine, and urea nitrogen, and had anti-inflammatory activities through down-regulating the secretions of ICAM-1, IL-1β, and IL-6 in the hyperuricaemia rat model.
5.4 Antioxidant Activity
Phellinus igniarius QB72 possessed higher polysaccharide production, stronger DPPH radical scavenging, and α-amylase inhibitory activity. Hot water extract polysaccharides exhibited higher DPPH radical scavenging and strong inhibitory activity against α-amylase with an IC50 value of 6.84 ± 0.37 mg/mL.
5.5 Antitumor Mechanisms
Previous research into antitumor mechanisms has focused on the direct inhibition of cancer cells. However, polysaccharides have attracted more attention due to their immunomodulatory effects. It has been demonstrated that developing cancer is able to avoid detection and escape the immune response. By adjusting or stimulating immune functions, the tumor cells may be recognized and targeted by the immune system.
5.6 Quorum-Sensing Inhibition
Research aimed to evaluate the different abilities of various Phellinus igniarius strains in inhibiting quorum sensing (QS), to search for novel QS inhibitors from them, and to analyze their inhibitory activity. The bioactive metabolites produced by P. igniarius cultures were tested for their abilities to inhibit QS-regulated behavior. P. igniarius strains can produce QS-inhibitory compounds and have different abilities to inhibit QS. Among the first reports of possible anti-QS activity from fungi, Phellinus igniarius and Ganoderma lucidum were found to suppress violacein production of Chromobacter violaceum.
6. Scientific Evidence by Area of Use
All human clinical evidence for Phellinus igniarius specifically is currently absent from the peer-reviewed literature. The totality of pharmacological research reviewed below consists of in vitro (cell-based) and in vivo (animal) studies. No human randomized controlled trials (RCTs) for P. igniarius as a dietary supplement have been identified. Evidence characterizations below reflect this limitation.
6.1 Immunomodulation
Evidence level: Preclinical (in vitro / animal models). A study from Yan'an University (2023) aimed to explore the immune-enhancing activity and underlying mechanisms of the polysaccharides and flavonoids derived from Phellinus igniarius (YASH1 strain) and to provide a theoretical and experimental basis for the development of novel drugs. P. igniarius contains both complex, high and low molecular weight natural bioactive compounds, the majority of which are triterpenoids, polysaccharides, and total flavonoids, which have important applications in antioxidant, immunity enhancement, and tumor suppression, as well as in the prevention and treatment of cirrhosis, ascites, hypoglycemia, and hypolipidemia. Pharmacological investigations have confirmed that bioactive polysaccharides and other important secondary metabolites from Phellinus spp. possess multiple health-promoting benefits, including antitumor, immunomodulatory, anti-inflammatory, antidiabetic, antioxidant, and antimicrobial effects. No human trials exist.
6.2 Antitumor / Anticancer Activity
Evidence level: Preclinical (in vitro and mouse xenograft models). MTT assay displayed that the total ethanol extract of P. igniarius (TPI) had antitumor activities against five human tumor cell lines: HepG-2, AGS, SGC-7901, Hela, and A-549. Phellinus igniarius is a traditional medicinal mushroom used in China and other countries of East Asia for the treatment of various diseases including cancer. TPI was found to have the most cytotoxicity against gastric cancer SGC-7901 in vitro, and strongly inhibited tumor growth in xenograft nude mice in vivo.
A study published in PubMed (2017) isolated compounds from P. igniarius and screened them against 41 human tumor cell strains. Compounds 2–4 exhibited significant cytotoxic activity against NOMO-1 and SKM-1 acute myeloid leukemia cell lines, and compound 7 showed remarkable antitumor activities against H526 human lung cancer cell line, DU145 prostate cancer cell line, and HEL erythroleukemia cell line, with IC₅₀ values of 0.533 4, 1.885, and 1.057 μmol/L, respectively. All compounds had no significant effect on hamster normal cell lines CHL and CHO, showing that all compounds had no toxic effect on normal cells.
In vivo antitumor efficacy was assessed in Kunming mice bearing H22 tumors, and Gansu PIP (GPIP) was identified to have a significantly higher antitumor efficacy compared with the control group (P<0.05). The in vitro MTT assay of GPIP on HepG2 cells indicated that GPIP had no direct cytotoxicity. The serum immune cytokines of interleukin-2, interleukin-12, and interferon-γ were assessed, suggesting the mechanism is immunomodulatory rather than directly cytotoxic.
In a separate animal study, P. igniarius extracts were orally administered to S180 tumor mice at 100, 200, and 400 mg/kg. P. igniarius extracts increased the spleen index and thymus index, and the inhibiting tumor rate was 31.88%, 46.25%, and 53.13% respectively. P. igniarius extracts also prolonged life in mice.
No human clinical trials for antitumor applications have been conducted for this specific fungus.
6.3 Anti-inflammatory Activity
Evidence level: Preclinical (in vitro, macrophage and animal models). A 2019 study published in the Journal of Exercise Rehabilitation investigated the antioxidative and anti-inflammatory effect of P. igniarius on RAW264.7 mouse macrophages. The MTT assay revealed that PI exerted no significant cytotoxicity in the RAW 264.7 macrophage cells. Inflammatory markers including PGE2, NO, COX-2, iNOS, IL-1α, IL-1β, IL-6, and TNF-α were all significantly suppressed in PI-treated groups compared to the LPS-stimulated group.
6.4 Anti-gout and Uric Acid Reduction
Evidence level: Preclinical (in vitro / rat models). A 2021 study published in Frontiers in Pharmacology comparatively investigated the therapeutic effects of wild and cultivated P. igniarius on hyperuricaemia and gouty arthritis in rat models. Wild and cultivated P. igniarius polyphenols showed similar activities in reducing uric acid levels through inhibiting xanthine oxidase activity and down-regulating ICAM-1, IL-1β, and IL-6 in the hyperuricaemia rat model. The pathological progression of kidney damage was also reversed. A separate PMC study confirmed the anti-gout mechanism through modulation of the TLR4/NF-κB/NLRP3 signaling pathway in a cellular model. P. igniarius is a valuable medicinal and edible fungus with various biological activities such as anti-inflammation, antioxidation, and immune regulation, and its effects on a gout model were explored in vitro.
6.5 Inflammatory Bowel Disease (Colitis)
Evidence level: Preclinical (mouse model). A 2018 study (PMC6173430) investigated the ameliorating effect of the aqueous extract of P. igniarius fruiting body on dextran sodium sulfate (DSS)-induced colitis in C57BL/6 mice. Treatment with SH (250 and 400 mg/kg) for 8 weeks effectively alleviated the pathological indicators of colitis such as bodyweight reduction, disease activity index score, shortening of colon length, and abnormal colon histology. The plasma levels of LPS and inflammatory factors such as IL-6, IL-1β, and TNF-α were all significantly reduced. These results suggest that the decoction of P. igniarius is adequate to ameliorate DSS-induced colitis and thus provides a potential utility for the treatment of colitis. No human data exist.
6.6 Neurological Protection and Multiple Sclerosis
Evidence level: Preclinical (mouse models). A PMC study aimed to evaluate the therapeutic potential of a mushroom extract from P. igniarius in an animal model of multiple sclerosis. The medicinal mushroom contains biologically active compounds that modulate the human immune system. Experimental autoimmune encephalomyelitis (EAE) was induced by immunization with MOG 35–55 in C57BL/6 female mice. A water-ethanol extract of P. igniarius (Piwep) was delivered intraperitoneally every other day for the entire experimental course. Piwep injection profoundly decreased the daily incidence rate and clinical score of EAE. Piwep-mediated inhibition was accompanied by suppression of demyelination and infiltration of encephalitogenic immune cells including CD4+ T cells, CD8+ T cells, macrophages, and B cells in the spinal cord. Piwep reduced expression of VCAM-1 in the spinal cord and integrin-α4 in the lymph node of EAE mice. Piwep also inhibited proliferation of lymphocytes and secretion of interferon-γ in the lymph node of EAE mice. The results suggest that a mushroom extract, Piwep, may have high therapeutic potential for ameliorating multiple sclerosis progression.
A 2015 PLOS ONE study (PMC4374876) investigated Phellinus igniarius, which has been used as traditional medicine in various Asian countries for many years. Although many reports exist on its anti-oxidative and anti-inflammatory activities, its effect on stroke is very limited. Following the 2005 discovery that acrolein produced from polyamines in vivo is a major cause of cell damage by oxidative stress, the study described the effects of anti-oxidative extracts from P. igniarius on symptoms of experimentally induced stroke in mice. The results suggested that Neuro-2a cells were protected from acrolein toxicity at 2 and 5 μM by this polyphenol extract at 0.5 and 2 μg/ml, respectively.
6.7 Antidiabetic / Hypoglycemic Activity
Evidence level: Preclinical (in vitro / mouse models). Phellinus spp. have historically been used as traditional medicines to treat various diseases owing to their antioxidant, antitumor, and antidiabetic activities. Polysaccharides exhibit antidiabetic activity. A 2023 Molecules study (PMC10609020) aimed to evaluate the effect of P. igniarius polysaccharides (SH-P) on improving hyperglycemia in mice with type 2 diabetes mellitus (T2DM) and clarified its association with gut microbiota. Fecal microbiota transplantation (FMT) was used to verify the therapeutic effects of microbial remodeling. SH-P supplementation alleviated hyperglycemia symptoms in T2DM mice, ameliorated gut dysbiosis, and significantly increased the abundance of Lactobacillus in the gut. Pathway enrichment analysis indicated that SH-P treatment altered metabolic pathways associated with the occurrence and development of diabetes.
In a separate study, hot water extract polysaccharides exhibited higher DPPH radical scavenging and strong inhibitory activity against α-amylase with an IC50 value of 6.84 ± 0.37 mg/mL. The α-amylase inhibitory activity IC50 was decreased (3.178 ± 0.187 mg/mL) after DEAE water elution. P. igniarius QB72 hot-water extracts of partially purified polysaccharides have great potential as α-amylase inhibitors.
6.8 Hepatoprotective Activity
Evidence level: Preclinical (mouse model). Phellinus igniarius (L.) Quèl, as a potential medicinal mushroom, possesses multiple biological activities including hepatoprotection, but the hepatoprotective mechanism is not clear. To elucidate the hepatoprotective effect, male C57BL/6 mice were fed with the Lieber–DeCarli diet containing alcohol with or without P. igniarius decoction (PID) at dosages of 0.65 g/kg and 2.6 g/kg. The levels of serum biomarkers were detected by an automatic biochemistry analyser. This study for the first time systematically illustrated the hepatoprotective effect of P. igniarius and preliminarily explored its potential target FXR. P. igniarius might be exploited as a promising therapeutic option for alcoholic liver injury.
6.9 Antiviral Activity
Evidence level: Preclinical / in vitro only. A series of studies have shown that P. igniarius has antiviral, anti-inflammatory, antioxidant, antineoplastic, and immunoregulatory pharmacological effects. Research indicates that polypores — a large group of fungi of the phylum Basidiomycota — exhibit antiviral, antimicrobial, anticancer, anti-allergic, anti-atherogenic, hypoglycemic, hepatoprotective, and anti-inflammatory activities. These findings are based on cell-culture and isolated-compound studies; no clinical antiviral trials have been conducted with P. igniarius.
7. Body Systems and Health Areas Associated with Willow Bracket
- Immune system: P. igniarius has long been used for clinical application and basic research to improve the immunity of the body.
- Gastrointestinal system: The medicinal mushroom Phellinus igniarius, called Sanghuang in Chinese, is a basidiomycetous fungus whose fruiting body has been widely used in Traditional Chinese Medicine to treat stomachache, inflammation, and tumors.
- Musculoskeletal / Uric Acid Metabolism: In several folk herbal medicine formulas or recipes, P. igniarius is used to treat stomach aches and arthritis.
- Metabolic / Endocrine system: The medicinal willow bracket mushroom, Phellinus igniarius, is a species that has been reported to possess antibacterial, antioxidative, antitumor, antidiabetic, and antihyperlipidemia activities.
- Liver: P. igniarius has important applications in the prevention and treatment of cirrhosis and ascites.
- Central nervous system: Neuroprotection and stroke evidence from preclinical data (see Section 6.6).
- Cardiovascular system: Tremulane sesquiterpenes from P. igniarius showed significant vasorelaxant activity in Sprague-Dawley mice, and the relaxation rate was approximately 46.6%.
8. Dosage Forms and Doses Reported in Studies
Phellinus igniarius is not edible as a whole mushroom — the Willow Bracket is not edible due to its tough, woody texture — and is therefore consumed exclusively in processed forms. The following dosages and forms appear specifically in published research:
- Aqueous extract (decoction): In the DSS-induced colitis mouse study, treatment with an aqueous extract of P. igniarius fruiting body (SH) at 250 and 400 mg/kg for 8 weeks effectively alleviated pathological indicators of colitis.
- Decoction (hepatoprotective study): Male C57BL/6 mice were fed with or without P. igniarius decoction (PID) at the dosage of 0.65 g/kg and 2.6 g/kg.
- Oral extract (antitumor, mouse): To study the inhibiting effect on S180 tumor, S180 mice were orally given 100, 200, and 400 mg/kg of P. igniarius extracts.
- Intraperitoneal water-ethanol extract (EAE/MS model): A water-ethanol extract of Phellinus igniarius (Piwep) was delivered intraperitoneally every other day for the entire experimental course in the EAE mouse model.
- Polyphenol extract (in vitro, stroke protection): Neuro-2a cells were protected from acrolein toxicity at 2 and 5 μM by this polyphenol extract at 0.5 and 2 μg/ml, respectively.
- Fruiting body powder extraction: Dried fruiting body powders were extracted with 70% ethanol (10% w/v) at 70°C for 16 hours.
No human clinical dosing regimens have been established for any indication. The above dosages apply only to the specific preclinical models in which they were used and cannot be extrapolated to human use.
9. Safety Considerations and Interactions
9.1 Iqmik: A Documented Safety Concern
The most thoroughly studied safety issue surrounding P. igniarius relates to its use in the Alaskan Native tobacco preparation iqmik. Iqmik is commonly believed to be a healthier alternative to commercially available dipping tobacco because there are no added chemicals. However, it is reported to deliver more nicotine than dipping tobacco. New information is disconcerting about the current widespread use of P. igniarius in many Alaska Native communities. The use of the mixture of fungus ash and tobacco is being studied and treated as a serious health concern. Museum collections indicate that use by Native Americans as a masticatory or for smoking purposes was widespread across North America. A nonrandomized, clinical observational pilot trial enrolled 60 pregnant Alaska Native women for assessment of iqmik and other tobacco use during pregnancy.
The ash of P. igniarius is highly alkaline (rich in magnesium, potassium, and other alkaline cations), which raises the pH of the tobacco mixture. This is understood to be the mechanism by which the ash increases the bioavailability and physiological impact of nicotine, contributing to higher nicotine delivery and risk.
9.2 Cytotoxicity in Cell Studies
The MTT assay revealed that PI exerted no significant cytotoxicity in the RAW 264.7 macrophage cells at the concentrations tested (50–400 μg/mL). However, cell-line safety data cannot be directly applied to whole-organism safety.
9.3 Physical Inedibility
Phellinus igniarius is woody and cork-like. It is physically impossible to chew or digest in its raw form and must be processed (decocted, extracted, or powdered) to derive bioactive compounds. Raw or unprocessed consumption is not feasible and would not deliver relevant bioactive components.
9.4 Absence of Human Toxicology Data
No formal human toxicological or pharmacokinetic studies for Phellinus igniarius extracts as a dietary supplement have been identified in the peer-reviewed literature. No safety data from clinical trials, no established tolerable upper intake levels, and no known drug interaction data from human studies exist at this time. Scientific evidence supporting health benefit claims is limited.
9.5 Habitat-Dependent Variation in Active Ingredients
Habitat remarkably affects the quality of medicinal fungi, resulting in differences in the active ingredients and medicinal value of medicinal fungi depending on the environment. This means that wild and cultivated specimens may differ substantially in polyphenol and polysaccharide content, complicating standardization for supplemental use.
10. Common Preparations (Summary)
- Hot-water decoction: The traditional method in East Asian medicine; extracts water-soluble polysaccharides and some phenolics.
- Ethanol extract: Used extensively in research to isolate flavonoids, phelligridins, and other polyphenols. Extraction with 70% ethanol at 70°C for 16 hours has been used in published research.
- Dried fruiting body powder: The basis for many preclinical studies; also the form used in some commercial supplement products.
- Fungal ash (iqmik): Prepared by burning the fungus from birch trees; the ash is mixed with leaf tobacco, pre-chewed in the mouth or mixed with water, and stored in containers for later use. This preparation is associated with documented tobacco-related health risks and is not a health supplement context.
11. Summary of Evidence Strength
P. igniarius is a traditional Chinese herbal medicine with a long history of application in China. In modern times, it has gradually become the focus of attention in China and abroad because of its outstanding regulation of immunity and its antitumor and antioxidant activities. Despite this longstanding traditional use and a growing body of preclinical investigation, the current evidence base for Phellinus igniarius as a human dietary supplement or therapeutic agent consists entirely of in vitro and animal studies. No human randomized controlled trials, systematic reviews, or pharmacopeial monographs for this specific species have been identified. Preclinical results — across immunomodulation, antitumor, anti-inflammatory, anti-gout, neuroprotective, antidiabetic, and hepatoprotective domains — are promising but preliminary. Translation to human efficacy and safety remains unestablished.
References
Go back